UK Venture Capital Raises £7.2bn in Q1 2026: 4 Reasons Wealth Managers Are Reviewing Portfolios Now

UK Venture Capital Raises £7.2bn in Q1 2026: 4 Reasons Wealth Managers Are Reviewing Portfolios Now

UK startups raised £7.2 billion in the first quarter of 2026, the highest quarterly total in four years and a 60% increase year-on-year, according to data published in April 2026. London accounted for £6.1 billion of that total — 85% of the national figure — driven by four headline-grabbing megadeals: AI infrastructure company Nscale raised £1.48 billion, autonomous vehicle company Wayve raised £1.1 billion, energy optimisation platform Kraken raised £744 million, and defence technology company Roark raised £232 million.

Four of Europe's ten largest venture capital investments in the quarter originated from Britain. At the same time, the government introduced sweeping policy changes that took effect in April 2026, reshaping how VC investments are taxed, structured, and accessed by ordinary investors. Together, these developments have placed UK venture capital at the top of wealth managers' agendas in a way it has not been for several years.

Here are the four questions a wealth management expert would be asking now — and why they matter to your portfolio.

1. Is This the Right Moment to Access the EIS/VCT Expansion?

The single most consequential change for UK individual investors in 2026 is the extension of the Enterprise Investment Scheme (EIS) and Venture Capital Trusts (VCT) by ten years, now running through 2035. Alongside the extension, the government widened the investment limits for both schemes from April 2026.

EIS allows UK taxpayers to invest in qualifying early-stage companies and claim 30% income tax relief on investments up to £1 million per year — rising to £2 million for knowledge-intensive companies. VCTs offer 30% income tax relief on up to £200,000 per year, with dividends and capital gains from the trust exempt from tax.

According to HMRC guidance on Enterprise Investment Scheme reliefs, these schemes exist specifically to channel private capital toward early-stage businesses that cannot access conventional funding. The ten-year extension, combined with April 2026's widened limits, means the planning certainty for high-net-worth individuals has not been stronger since EIS was introduced in the 1990s.

A wealth manager's job in 2026 is to help clients assess whether EIS or VCT allocation makes sense given their income tax position, risk tolerance, and existing alternative asset exposure. The extension removes the urgency-driven question of scheme longevity — but it does not remove the need for individual suitability analysis.

2. How Much AI and Biotech Concentration Risk Are You Carrying?

The Q1 2026 data reveals a significant concentration dynamic. UK AI startups raised a record $5.8 billion in the quarter — equivalent to 74% of all venture capital raised in the country. More than 100 individual AI funding rounds completed in Q1, and the UK created seven new AI unicorns, approximately twice the rate of any other European country.

Biotech followed a strong line: UK biotech venture capital reached £516 million in Q1 2026, a 17% quarterly increase and 67% higher in transaction volume year-on-year, according to data from the BioIndustry Association. The sector's strength was underscored by two major acquisitions — Eli Lilly's purchase of UK-based Centessa Pharmaceuticals for £4.6 billion, and Amgen's acquisition of Dark Blue Therapeutics for £626 million.

For portfolio purposes, this concentration raises a specific question for clients already holding EIS investments from previous years. Many EIS portfolios assembled between 2020 and 2024 have significant tech and life sciences weighting by default — these were the sectors with the most qualifying deal flow. Adding further VC exposure in 2026 without reviewing existing allocation risks doubling down on AI and biotech at precisely the point where megadeal valuations are highest.

A wealth manager reviewing an existing portfolio should model the combined sector exposure across all alternative asset holdings — not just VC in isolation.

3. How Does the Carried Interest Change Affect the Funds You Evaluate?

From April 2026, the tax treatment of carried interest — the profit share that VC fund managers receive — moved fully into the income tax framework. This follows a rate increase from 28% to 32% that came into force in April 2025. Reliefs are designed to maintain broadly comparable effective rates for most fund managers, but the structural change has already begun reshaping how UK VC funds are structured and how managers are compensated.

For investors evaluating which VC funds to access — either directly or through a VCT — the carried interest change has a downstream effect on net returns. Funds with higher carry percentages and older waterfall structures are adjusting their terms in ways that affect investor economics. Understanding how a specific fund's carry structure works, and how the April 2026 changes interact with it, has become a material due diligence question.

This is a technical area where a wealth manager with VC fund experience adds real value — the headline tax rate tells you relatively little about the actual after-tax economics of a specific fund structure.

4. Does Your Pension Now Have VC Exposure You Did Not Choose?

The government's National Wealth Fund — a merger of the UK Infrastructure Bank and the British Business Bank — launched with £27.8 billion in capitalisation in 2026. Alongside this, the British Business Bank received approval for the "British Growth Partnership," which for the first time opens institutional VC co-investment pipelines to UK pension funds.

This change has a subtle but important implication for individual investors: if your workplace or personal pension is managed by a large UK institutional provider, it may now have exposure to UK venture capital through this channel without any direct decision on your part. The British Growth Partnership is designed to channel pension capital into growth companies — the exact segment that EIS and VCT schemes target on the retail side.

Clients who have historically said "I don't invest in startups" should now verify this assumption with their pension provider. The answer to the question "do you have any VC exposure?" is no longer straightforwardly "no" for many UK pension holders.

Talking to a Wealth Management Expert in 2026

The combination of record deal flow, significant tax incentive expansion, sector concentration risk, and structural pension changes makes 2026 a genuinely complex year for UK investors thinking about venture capital exposure. The questions are not academic: EIS investment decisions made in the 2026-27 tax year have direct income tax and capital gains consequences that will play out for a decade.

A qualified wealth management adviser can help you assess whether EIS or VCT allocations suit your overall tax position and risk profile, review existing alternative asset exposure for concentration risk, evaluate specific fund structures and their interaction with the April 2026 carried interest changes, and determine whether your pension now carries indirect VC exposure that should inform other decisions.

The Q1 2026 data is unambiguous — capital is flowing into UK venture at speed. Whether that flow should include your money, and how much, is a personalised question that deserves a personalised answer.

Financial disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Tax reliefs depend on individual circumstances and may change. Consult a qualified financial adviser before making investment decisions.